You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 151 No. 6, JUNE 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Should the Elderly Be Screened for Hypercholesterolemia?

John M. Eisenberg, MD

Arch Intern Med. 1991;151(6):1063-1065.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Growing concern about the financial burden of medical care—on taxpayers, employers, and individuals—has focused attention on the appropriateness and efficiency of clinical strategies. The new Agency for Health Care Policy and Research was established by Congress in 1989 in large part to stimulate and support research that will lead to the development and application of guidelines for effective use of available resources for health. This advice will be aimed in several directions—at payers to guide decisions about which services to cover, at health care systems (eg, hospitals, health maintenance organizations) about which services to make available, and at clinicians and the public about which services to provide and receive.

This trend of analyzing the cost and effectiveness of clinical strategies is an international one. For example, in 1987, the Australian government enacted legislation to require that cost-effectiveness be considered in decisions about which drugs will be included in the National . . . [Full Text PDF of this Article]


Author Affiliations

Section of General Internal Medicine/ Department of Medicine and Leonard Davis Institute of Health Economics University of Pennsylvania 3400 Spruce St Philadelphia, PA 19104



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.